Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dolvis Bio Pharma is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat, specializing in the manufacturing, marketing, and distribution of a diverse range of pharmaceutical formulations. The company's product portfolio encompasses various dosage forms, including tablets, capsules, injectables, and oral liquids, targeting therapeutic areas such as anti-infectives, analgesics, gastroenterology, and gynecology. Dolvis Bio Pharma primarily operates through a PCD (Propaganda Cum Distribution) franchise model, providing marketing rights and support to distributors across various regions in India. The company emphasizes quality control and adheres to Good Manufacturing Practices (GMP) to ensure the efficacy and safety of its healthcare products. By focusing on affordable generic and branded formulations, Dolvis Bio Pharma aims to cater to the growing healthcare needs of the domestic Indian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dolvis Bio Pharma.